Loading viewer...
investor_presentation
Format: PDF investor_presentation
Virpax Pharmaceuticals is developing innovative delivery platform technologies for non-addictive pain and neurological disorder treatments through collaborations with the NIH and DOD. The company addresses multi-billion-dollar markets with differentiated therapeutic approaches.
investor_presentation
29 Pages
investor_presentation
35 Pages
SWK Holdings
investor_presentation
Ternium